A Study of Stellate Ganglion Block for Prevention of Atrial Fibrillation — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study of Stellate Ganglion Block for Prevention of Atrial Fibrillation — Stella

Home/Atrial Fibrillation/

View on ClinicalTrials.gov

Recruiting

Back to Atrial Fibrillation trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Mayo Clinic in Rochester, Rochester, Minnesota

Key details

Phase

Safety & dosing / Large-scale testing

Sponsor

Mayo Clinic

Enrollment target

~220 participants

Started

April 2023

Primary completion

April 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

60 Years and older

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.